Novella-Navarro, Marta http://orcid.org/0000-0002-2200-0859
Plasencia, Chamaida
Tornero, Carolina
Navarro-Compán, Victoria
Cabrera-Alarcón, José L.
Peiteado-López, Diana
Nuño, Laura
Monjo-Henry, Irene
Franco-Gómez, Karen
Villalba, Alejandro
Balsa, Alejandro
Article History
Received: 27 April 2020
Accepted: 15 October 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: The study was approved by the local medical ethics committee (PI-1155). And consent information was obtained from all participants.
: Not applicable.
: No competing interests applicable regarding this manuscript, but A.B. has received grant/research support and fees for consultancies or as a speaker from Abbvie, Amgen, Pfizer, Novartis, BMS, Nordic, Sanofi, Sandoz, Lilly, UCB, and Roche. C.P.R. has received speaking fees or funding for research projects from Pfizer, Lilly, Novartis, Abbvie, and Roche. V.N.C. has received research grants from Abbvie, Merck, Novartis, Pfizer, and ASAS and consulting fees from Abbvie, Lilly, Novartis, Pfizer, and UCB.